Tag Archives: sodium dichloroacetate

News & views in ME/CFS: the role of co-morbidity & novel treatments

Posted on 02/19/2020 by wames

News and views in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): The role of co-morbidity and novel treatments, by F Comhaire, JP Deslypere in Medical Hypotheses Vol 134, January 2020, 109444 [doi.org/10.1016/j.mehy.2019.109444]   Research abstract: Though affecting many thousands of patients, myalgic … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on News & views in ME/CFS: the role of co-morbidity & novel treatments

Why do some ME/CFS patients benefit from treatment with sodium dichloroacetate, but others do not?

Posted on 10/02/2018 by wames

Why do some ME/CFS patients benefit from treatment with sodium dichloroacetate, but others do not?, by Frank Comhaire in Med Hypotheses 2018 Nov;120:65-67 [Epub 2018 Aug 25] Research abstract: Myalgic Encephalopathy/Chronic Fatigue Syndrome (ME/CFS) is an enigmatic disease the pathogenesis of which remains … Continue reading →

Posted in News | Tagged , , | Comments Off on Why do some ME/CFS patients benefit from treatment with sodium dichloroacetate, but others do not?

Treating patients suffering from (ME/CFS) with sodium dichloroacetate: a pilot trial

Posted on 03/14/2018 by wames

Research abstract: Treating patients suffering from myalgic encephalopathy/chronic fatigue syndrome ME/CFS) with sodium dichloroacetate: An open-label, proof-of-principle pilot trial, by Frank Comhaire in Medical hypotheses May 2018 Vol 114, Pp 45–48 Twenty-two consecutive patients suffering from refractory myalgic encephalitis/chronic fatigue syndrome … Continue reading →

Posted in News | Tagged , , , , | Comments Off on Treating patients suffering from (ME/CFS) with sodium dichloroacetate: a pilot trial